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ABSTRACT 
Objective: The following study aimed to investigate the efficacy of curcumin at preventing amikacin neurotoxicity  
Methods: Twenty-four male Wister albino rats were randomly divided into four groups including-G (1): control group includes six rats, they were 
administered 0.5 ml of saline orally for 14 consecutive days. G (2): includes six rats; they were administered 200 mg/kg curcumin orally for 14 
consecutive days. G (3): includes six rats, they were administered 300 mg/kg body weight/day of amikacin intraperitoneally for 14 consecutive days 
G (4): includes six rats, they were administered 200 mg/kg curcumin orally concurrently with 300 mg/kg body weight/day of amikacin. All animals 
were kept in the same conditions from feed, heat and humidity. 
Results: According to the result obtained after sacrification of all animals after the end of 14 d, Results revealed that amikacin at the dose rate of 
300 mg/kg b. wt for 14 d induces significant changes in oxidative stress markers compared to the control group, a significant reduction in CAT. SOD. 
GSH (1.51±0.16, 77.00±0.73 and 84.06±4.42) respectively compared to control (3.63±0.11, 98.48±0.18 and 117.05±0.52) along with a significant 
increase in MDA activity (219.02±3.34) compared to control group (180.42±0.19), That indicate oxidative stress effect of it. On the beneficial side 
rats received amikacin 300 mg/kg B. wt I/p concurrently with 200 mg/kg b. wt curcumin for successive 14day result in a significant increase in 
CAT. SOD. GSH (2.23±0.09,92.00±0.26, 102.25±1.71) and decrease in MDA concentration (139.23±3.89) compared to amikacin treated group levels 
along with histopathological changes appear in brain tissue in the group treated with amikacin include nuclear pyknosis and degeneration in some 
neurons in the hippocampus, multiple focal eosinophilic plaque formation in the striatum also this results enhanced by activated caspase-3 
expression in the brain tissue following amikacin administration. 
Conclusion: The present study proved that Oral administration of curcumin at the dose of 200 mg/kg for 14 d concurrently with amikacin 
significantly mitigates its neurotoxic and oxidative stress effects. 
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INTRODUCTION 
Amikacin is a broad-spectrum aminoglycoside antibiotic derived 
from kanamycin and is highly effective against gram-negative 
organisms (including gentamycin-resistant strains) as well as a few 
gram-positive organisms [1]. It binds mainly to 30s ribosomes and 
interferes with the initiation of protein synthesis, block the 
translation of mRNA and prematurely terminate the protein 
synthesis. Like other aminoglycosides, it may cause nephrotoxicity, 
hepatotoxicity, ototoxicity, and neuromuscular block [2, 3].  
Medicinal plants have been used by all civilizations since ancient 
times. Increasing risk of antibiotic side effects and resistance push 
scientists to pay attention to herbal extracts. One of them is Curcumin 
is one of the most important medicinal plants. it is a herbaceous plant 
belonging to the ginger family, it extracts from the rhizomes of plant of 
curcuma longa [4], it exhibits a variety of therapeutic properties, 
including antioxidant [5], antiapoptotic activities [6, 7]. It has a strong 
potency in inhibiting the generation of reactive oxygens species (ROS). 
Notably, curcumin can cross the blood-brain barrier suggesting a 
possible cause of neuroprotective effect [8]. 
So the objective of this study is to investigate the neurotoxic effect of 
amikacin on brain tissue and the neuroprotective role of curcumin. 
MATERIALS AND METHODS 
Chemicals 
Amikacin (amikacin) was obtained as a patent preparation (Pharco 
company this is an I/V and I/M therapy. It is given by intraperitoneal 
injection at the dose rate of 100 mg/kg body weight/day previously 
described by [9] 
Curcumin extract was obtained from National Research Center, Cairo, 
Egypt. It was used at a dose of 200 mg/kg b. wt orally for 14 d [10]. 
Animals  
Twenty-four Wister albino rats weighing 200-250 gm were used in 
this investigation. They were obtained from the Animal House of the 
faculty of veterinary medicine, Benha University. They are fed on a 
normal rodent diet and apply water ad libtum. Rats were left for a 
week for acclimatization before the beginning of the experiment. 
Rats were treated in accordance with the guidelines for animal 
experimentation of ethics review committee of faculty of veterinary 
medicine, Benha University Number (BUFVTM 010321).  
Experimental design 
Rats were divided into 4 groups. 
Group (1): Served as a control group and it includes six rats; they 
were administered 0.5 ml of saline orally for 14 consecutive days  
Group (2): it includes six rats; they were administered 200 mg/kg 
curcumin orally for 14 consecutive days. 
Group (3): it includes six rats; they were administered 300 mg/kg body 
weight/day of amikacin intraperitoneally for 14 consecutive days. 
Group (4): it includes six rats; they were administered 200 mg/kg 
curcumin orally concurrently with 300 mg/kg body weight/day of 
amikacin intraperitoneally for 14 consecutive days. 
Evaluation of oxidative stress markers 
The brain was taken immediately after sacrification, washed in 
physiological saline. Half of the brain was preserved at–80 0c until 
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preparation of tissue homogenate which is used for assessment of 
(MDA, CAT, GSH, and SOD) levels colorimetrically according to [11-14].  
Respectively 
Histopathology and immunohistochemistry 
Another half of the brains were taken from the brain of rats in 
different groups and fixed in formalin solution 10% for twenty-four 
hours. .The obtained tissue sections were collected on glass slides, 
deparaffinized, and stained by hematoxylin and eosin stain for 
routine examination through the light microscope [15]. 
Another group of embedded paraffin sections was also prepared for 
immune detection of caspase 3 positive cells using an avidin-biotin-
peroxidase (ABC) methods [16] 
Statistical analysis 
First, all data are tested for normality and homogeneity then, one-
way analysis of variance (ANOVA) used to determine the Statistical 
differences among groups followed by Duncan’s multiple ranges as 
post hoc for making multiple comparisons using the Statistical 
Package for Social science Software (SPSS (25) software (SPSS Inc., 
Chicago, USA). The values were expressed as mean±standard error 
of studied groups. 
RESULTS 
Results showed that the administration of amikacin at the dose rate 
of 300 mg/kg b. wt for 14 d induces significant changes in oxidative 
stress markers compared to the control group, a significant 
reduction in CAT. SOD. GSH (1.51±0.16, 77.00±0.73 and 84.06±4.42) 
respectively compared to control (3.63±0.11, 98.48±0.18 and 
117.05±0.52) along with a significant increase in MDA activity 
(219.02±3.34) compared to the control group (180.42±0.19). On the 
beneficial side rats received amikacin 300 mg/kg B. wt I/p 
concurrently with 200 mg/kg b. wt curcumin for successive 14day 
result in a significant increase in CAT. SOD. GSH 
(2.23±0.09,92.00±0.26, 102.25±1.71) and decrease in MDA 
concentration (139.23±3.89) compared to amikacin treated 
group table 1.2, fig. 1.2.  
Histopathological finding 
Light micrograph of brain tissue found that no histopathological 
alteration recorded in both cerebral cortex, hippocampus, and 
striatum fig. 3 (A, B, C) whereas in the same of that from curcumin 
group fig. 3 (E, F, G) but they varied with that from amikacin treated 
rats that showing nuclear pyknosis and degeneration of some neurons 
of the hippocampus and multiple focal eosinophilic plaque formation 
in the striatum fig. 3 (H, I). On the other hands, in the case of sections 
from the amikacin and curcumin-treated group found a great 
protective effect of curcumin represented in no histopathological 
alteration in both cerebral cortex and hippocampus beside only some 
eosinophilic plagues formation in the striatum fig. 3 (J, K, L) 
Immunohistochemical finding 
The immunohistochemical finding of Caspase 3, in brain tissue. 
Showed a change in caspase 3 expression after treatment with 
curcumin, amikacin, and curcumin with amikacin. The reaction in 
the brain is localized in the neuron. Immunostaining was performed 
using anti caspase 3. The severity of the immunohistochemical 
reaction is depending on the density and distribution of dark brown 
coloration. Mild expression (+) was found in the amikacin group for 
caspase 3, while Nil expression (-) was found in other groups, table 
3, fig. 4 (A, B, C, D). 
 
Table 1: Effect of oral administration of curcumin at 200 mg/kg 
body weight for successive 14 d on MDA in amikacin (300 







Data are represented as (mean of 6 rats±SE). Mean values with 
different superscriped letters in the same column are significantly 
different at (P<0.05). 
 
 
Fig. 1: Effect of oral administration of curcumin at 200 mg/kg body weight for successive 14 d on reduced Glutathione (GSH) 
concentration in amikacin (300 mg/kg b. wt.) treated rats. (n=6). Data are represented as (mean of 6 rats±S. E) Mean values with different 
superscriped letters in the same column are significantly different at (P<0.05) 
 
Table 2: Effect of oral administration of curcumin at 200 mg/kg body weight for successive 14 d on Superoxide dismutase (SOD) 





92.00±0.26Pc Concurrent Amikacin+Curcumin 
Data are represented as (mean of 6 rats±SE). Mean values with different superscripted letters in the same column are significantly different at (P<0.05) 
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Fig. 2: Effect of oral administration of curcumin at 200 mg/kg body weight for successive 14 d on catalase (CAT) Concentration in 
amikacin (300 mg/kg b. wt) treated rats. (n=6). Data are represented as (mean of 6 rats±SE). Mean values with different superscripted 
letters in the same column are significantly different at (P<0.05) 
 
Table 3: Effect of oral administration of curcumin at 200 mg/kg body weight for successive 14 d on caspase 3 expression of amikacin (300 
mg/kg b. wt) treated rat’s brain 








Fig. 3: Histopathological changes in brain tissue (A,B,C) cerebral cortex, hippocampus and striatum of brain of Control group found no 
histopathological ulteration, (D,E,F), cerebral cortex, hippocampus and striatum of brain of Curcumin treated group also found no 
histopathological ulteration, (G), cerebral cortex of brain of amikacin treated group also found no histopathological ulteration, (H) 
hippocampus of brain of amikacin treated group, nuclear pyknosis and degeneration were detected in some neurons, (I) multiple focal 
eosinophilic plagues formation were detected in striatum of brain of amikacin treated group, (J) cerebral cortex of concurrent group 
(Amikacin and curcumin) no histopathological alteration was detected, (K) some nuclear pyknosis and degeneration were detected in 
some neurons hippocampus of concurrent group (Amikacin and curcumin), (L), no histopathological alteration recorded in the striatum 
of the concurrent group (Amikacin and curcumin) immunohistochemistry 
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Fig. 4: Effect of oral administration of curcumin at 200 mg/kg body weight for successive 14 d on Caspase 3 expression of amikacin (300 
mg/kg b. wt. b. wt treated rats brain. A: control group. B: curcumin group. C: Amikacin group. D: concurrent group. The severity of the 
immunohistochemical reaction is depending on the density and distribution of brown dark coloration. Mild expression (+) was found in 
the amikacin group (C) for caspase 3, while nil expression (-) was found in other groups (A, B, D) 
 
DISCUSSION 
A great rule of aminoglycoside in the treatment of gram-negative 
bacteria increases the interest in its usage but the favor of 
neurotoxicity restricts its use. So improvement of neurotoxicity will 
open the window for using a higher dose of amikacin; beside that the 
fact that Curcumin has antioxidant and anti-apoptotic activity [5, 7, 
17], that induce neuroprotective effects [18, 19], This study was 
conducted to assess the potential protective effect of curcumin 
against amikacin induced neurotoxicity. 
Cells contain several antioxidants to prevent and repair cell damage 
CAT enzymatic antioxidant catalase H202 to water and 
oxygen [20]. GSH is a cofactor for several enzymes, it plays a role in 
detoxifying hydrogen peroxidase and lipid peroxidase through its 
action on glutathione peroxidase GSH px it protects the cell against 
apoptosis by interacting with the pro-apoptotic signal pathway [21]. 
MDA is a biomarker of oxidative stress; the degree of lipid 
peroxidation can be estimated by the amount of malondialdehyde in 
tissue [22]. Reactive oxygen species degrade polyunsaturated lipids 
forming malondialdehyde [23]. This component is a reactive 
aldehyde and is one of the many reactive electrophile species that 
cause toxic stress in cells [24]. Superoxide dismutase (SOD) is 
reasonable for the catalytic decomposition of superoxide anion into 
oxygen and hydrogen peroxide [25].  
Curcumin has neuroprotective characteristics. It has antioxidant 
activity anti-inflammatory and anti-protein aggregate activity [26].  
The imbalance between oxidants and antioxidants in favor of 
oxidants is referred to as oxidative stress [27]. Oxidative stress plays 
a great role in many diseases and also in various types of drug-
induced liver, heart brain, and renal toxicity [28, 29].  
During investigation revealed that intraperitoneal injection of amikacin 
with a dose rate of 300 mg/kg b. wt. once daily for 14 d produce 
oxidative stress in brain tissue which is evidenced with significantly 
lowered antioxidant activity (CAT, GSH, SOD) along with increase free 
radical-mediated damage as evidence of increased MDA level. This result 
was in harmony with that investigated by [30] in the liver and kidney. 
Interestingly, our results indicated that administration of 200 mg/kg 
b,wt curcumin concurrently with amikacin for 14 d protect brain tissues 
against amikacin induced oxidative stress via improvement of the 
antioxidant status (CAT, GSH, SOD) and consequently reduced lipid 
peroxidation (MDA)concentration this amelioration of 
oxidant/antioxidant status of brain tissue by curcumin could be 
attributed to direct reduction of ROS generation and 
release [31], scavenging of the free radicals and subsequent inhibition of 
oxygenation reaction as curcumin has been reported to be a good 
antioxidant and free radical scavenger, inhibit lipid 
peroxidation [5]. Curcumin may reduce lipid peroxidation by enhancing 
the activities of antioxidant enzymes and GSH levels as they play an 
essential role in lipid peroxidation regulation [32, 33]. Together, these 
mechanisms may explain, at least in part, the cytoprotective effect of 
curcumin which confirm by the improvement of the brain structure of 
sections from the concurrent group.  
Likewise, curcumin administration to rats at an oral dose of 200 
mg/kg b. et for 10 d significantly increased SOD and GSH levels as 
well as histopathological findings of gentamycin-treated rats [10]. 
Apoptosis is a physiological process for removing unwanted cells during 
development and for maintaining tissue homeostasis [34]. Deregulation 
of this process causes several disorders like neurodegenerative 
disorder [35]. Caspases are crucial mediators of apoptosis among them: 
Caspase 3 is frequently activated death protease, catalyzing the specific 
cleavage of many key cellular proteins [36] and lead to DNA breakdown, 
which is one of the characteristic cellular changes of apoptosis [37]. 
Fourthinatly, In the present study curcumin, could ameliorate the effect 
of amikacin on the expression level of caspase 3 in the concurrent group. 
these results in mat be caused by the ability of curcumin to prevent GSH 
decrease, thus protecting the cell from caspase 3 activation and DNA 
fragmentation [38]. On the same line, [39] concluded downregulation of 
caspase 3 expression, as well as elevation of intracellular GSH level in 
manganese exposed microglial cells.  
CONCLUSION 
The present study proved that, Oral administration of curcumin at 
the dose of 200 mg/kg for 14 d concurrently with amikacin result 
imporvment to antioxidant activity and it is illustrated by significant 
increase in CAT. SOD. GSH and decrease in MDA concentration 
compared to amikacin intoxicated group levels along with a great 
protective effect of curcumin represented in no histopathological 
alteration in both cerebral cortex and hippocampus beside only 
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